| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.99B | +4.7% |
| Cost of Revenue | $1.62B | +7.3% |
| R&D Expense | $470.9M | +16.0% |
| SG&A Expense | $621.8M | +3.5% |
| Operating Income | $533.4M | -16.3% |
| Interest Expense | $27.1M | +53.1% |
| Pre-tax Income | $587.0M | -10.0% |
| Income Tax | $82.1M | -22.8% |
| Net Income | $504.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $517.7M | +5.8% |
| Short-term Investments | $1.08B | +187.7% |
| Accounts Receivable | $727.7M | +0.5% |
| Current Assets | $2.58B | +42.8% |
| Total Assets | $10.37B | +4.7% |
| Current Liabilities | $2.09B | +150.1% |
| Total Liabilities | $5.49B | +3.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.52B | +12.7% |
| Capital Expenditures | $390.4M | -14.7% |
| Investing Cash Flow | -$798.7M | +56.8% |
| Financing Cash Flow | -$679.6M | -253.3% |
| Free Cash Flow | $1.13B | +26.7% |
| -7.8% |
| EPS (Basic) | $3.34 | -7.0% |
| EPS (Diluted) | $3.27 | -7.1% |
| Stockholders' Equity |
| $4.88B |
| +6.1% |